Literature DB >> 28243744

Toll-like receptor 7 gene single nucleotide polymorphisms and the risk for systemic lupus erythematosus: a case-control study.

I I Raafat1, N El Guindy1, R M H Shahin2, L A Samy1, R M El Refai3.   

Abstract

BACKGROUND: Toll-like receptors (TLRs) are a family of pattern-recognition receptors which play a role in eliciting innate/adaptive immune responses and developing chronic inflammation. So, the aim of this study was to analyze the effect of TLR7 gene single nucleotide polymorphisms (SNPs) rs3853839 and rs179019 on systemic lupus erythematosus (SLE) susceptibility and to assess their relations with various clinical and laboratory data of the patients.
METHODS: This is a case-control study including 50 SLE female patients and 50 healthy controls. TLR7 rs3853839 and rs179019 genotyping was performed using real-time polymerase chain reaction (PCR) TaqMan-based allelic discrimination assay.
RESULTS: Regarding rs3853839, there was a statistically significant difference in the distribution of the genotypes between SLE patients and the control group in our study (P = 0.009). A significant association was detected between TLR7 genotypes (rs385389) and lupus nephritis (p = 0.021). Regarding rs179019, there was no statistically significant difference in the distribution of the genotypes between SLE patients and the control group in our study (P = 0.271)
CONCLUSION: This study revealed the plausible role of TLR7 rs3853839 SNP in SLE in Egyptian women.

Entities:  

Keywords:  Lupus nephritis; Real time polymerase chain reaction TaqMan-based allelic discrimination assay; Single nucleotide polymorphisms (SNPs); Systemic lupus erythematosus (SLE); Toll-like receptor 7 (TLR7)

Mesh:

Substances:

Year:  2018        PMID: 28243744     DOI: 10.1007/s00393-017-0283-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  17 in total

Review 1.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 2.  Regulation of immunity and oncogenesis by the IRF transcription factor family.

Authors:  David Savitsky; Tomohiko Tamura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Cancer Immunol Immunother       Date:  2010-01-05       Impact factor: 6.968

3.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

Review 4.  MicroRNAs: the fine-tuners of Toll-like receptor signalling.

Authors:  Luke A O'Neill; Frederick J Sheedy; Claire E McCoy
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

5.  Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.

Authors:  Beverly D Lyn-Cook; Chenghui Xie; Jarren Oates; Edward Treadwell; Beverly Word; George Hammons; Kenneth Wiley
Journal:  Mol Immunol       Date:  2014-05-24       Impact factor: 4.407

6.  Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome.

Authors:  R Hal Scofield; Gail R Bruner; Bahram Namjou; Robert P Kimberly; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Graciela S Alarcón; Luis M Vilá; Jeff Reid; Bryan Harris; Shibo Li; Jennifer A Kelly; John B Harley
Journal:  Arthritis Rheum       Date:  2008-08

Review 7.  Targeting Toll-like receptors for treatment of SLE.

Authors:  Christopher G Horton; Zi-jian Pan; A Darise Farris
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

8.  Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females.

Authors:  Magdalena Janina Laska; Anne Troldborg; Bettina Hansen; Kristian Stengaard-Pedersen; Peter Junker; Bjørn Andersen Nexø; Anne Voss
Journal:  Rheumatology (Oxford)       Date:  2013-09-24       Impact factor: 7.580

Review 9.  Toll-like receptors and autoimmunity.

Authors:  Julia Hurst; Philipp von Landenberg
Journal:  Autoimmun Rev       Date:  2007-12-04       Impact factor: 9.754

10.  Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus.

Authors:  C Enevold; C H Nielsen; R S Jacobsen; M L F Hermansen; D Molbo; K Avlund; K Bendtzen; S Jacobsen
Journal:  Mol Biol Rep       Date:  2014-06-12       Impact factor: 2.742

View more
  6 in total

Review 1.  Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.

Authors:  Giulia Frazzei; Ronald F van Vollenhoven; Brigit A de Jong; Sarah E Siegelaar; Dirkjan van Schaardenburg
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

2.  Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus Erythematosus.

Authors:  Sarah Kiener; Camillo Ribi; Irene Keller; Carlo Chizzolini; Marten Trendelenburg; Uyen Huynh-Do; Johannes von Kempis; Tosso Leeb
Journal:  Genes (Basel)       Date:  2021-08-19       Impact factor: 4.096

3.  High TLR7 Expression Drives the Expansion of CD19+CD24hiCD38hi Transitional B Cells and Autoantibody Production in SLE Patients.

Authors:  Ting Wang; John Marken; Janice Chen; Van Bao Tran; Quan-Zhen Li; Mengtao Li; Karen Cerosaletti; Keith B Elkon; Xiaofeng Zeng; Natalia V Giltiay
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 4.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

5.  COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities.

Authors:  Sally M El-Hefnawy; Hanaa A Eid; Rasha G Mostafa; Shaimaa S Soliman; Thoria A Omar; Rania M Azmy
Journal:  Gene Rep       Date:  2022-04-18

Review 6.  Association of Immune-Related Genetic and Epigenetic Alterations with Lupus Nephritis.

Authors:  Xiaole Mei; Hui Jin; Ming Zhao; Qianjin Lu
Journal:  Kidney Dis (Basel)       Date:  2022-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.